| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0067 | 0.9 |